Structure |
Chemical Name |
CAS |
MF |
![Ropivacaine Impurity 42](/) |
Ropivacaine Impurity 42 |
|
|
![Sugammadex sodium Org197339-1 Impurity](/) |
Sugammadex sodium Org197339-1 Impurity |
|
|
![Fludarabine EP impurity G](/CAS/20210111/GIF/548774-56-7.gif) |
Fludarabine EP impurity G |
548774-56-7 |
C10H12ClFN5O6P |
![Sitagliptin Impurity 12](/CAS/20210111/GIF/1803026-54-1.gif) |
Sitagliptin Impurity 12 |
1803026-54-1 |
C16H12F6N4O |
![Butyphthalide impurity 44](/CAS/20210111/GIF/952413-01-3.gif) |
Butyphthalide impurity 44 |
952413-01-3 |
C13H18O3 |
![Cabozantinib impurity 24](/) |
Cabozantinib impurity 24 |
|
|
![Celecoxib Impurity 18](/CAS/20200119/GIF/CB24842244.gif) |
Celecoxib Impurity 18 |
2271123-54-5 |
C11H9F3O2 |
![Dapoxetine impurity 22](/) |
Dapoxetine impurity 22 |
|
|
![Febuxostat Impurity 85](/) |
Febuxostat Impurity 85 |
|
|
![Fosaprepitant Impurity NLS](/) |
Fosaprepitant Impurity NLS |
|
|
![Irinotecan Impurity 17 HCl](/CAS/20210111/GIF/1332610-75-9.gif) |
Irinotecan Impurity 17 HCl |
1332610-75-9 |
C19H14N2O4 |
![LCZ696(valsartan + sacubitril) impurity 31](/) |
LCZ696(valsartan + sacubitril) impurity 31 |
|
|
![Lenvatinib Impurity 24](/) |
Lenvatinib Impurity 24 |
|
|
![Lenvatinib Impurity 30](/) |
Lenvatinib Impurity 30 |
|
|
![Regorafenib Impurity 22](/) |
Regorafenib Impurity 22 |
|
|
![Regorafenib Impurity 28](/) |
Regorafenib Impurity 28 |
|
|
![Sitafloxacin Impurity ZZ-C-01](/) |
Sitafloxacin Impurity ZZ-C-01 |
|
|
![Tofacitinib Impurity 85](/CAS/20210111/GIF/2268720-86-9.gif) |
Tofacitinib Impurity 85 |
2268720-86-9 |
C20H24ClN5 |
![(E)-methyl 3-(((4-(N-methyl-2-(4-methylpiperazin-1-yl)acetamido)phenyl)amino)(phenyl)methylene)-2-oxoindoline-6-carboxylate](/) |
(E)-methyl 3-(((4-(N-methyl-2-(4-methylpiperazin-1-yl)acetamido)phenyl)amino)(phenyl)methylene)-2-oxoindoline-6-carboxylate |
|
|
![2-フルオロ-4-アセチル-1,1'-ビフェニル](/CAS/GIF/42771-79-9.gif) |
2-フルオロ-4-アセチル-1,1'-ビフェニル |
42771-79-9 |
C14H11FO |
![4-ヒドロキシベンゼン-1,3-ジメタノール](/CAS/GIF/2937-60-2.gif) |
4-ヒドロキシベンゼン-1,3-ジメタノール |
2937-60-2 |
C8H10O3 |
![Oseltamivir Impurity 107](/) |
Oseltamivir Impurity 107 |
|
|
![Oseltamivir Impurity 66](/) |
Oseltamivir Impurity 66 |
|
|
![Dapagliflozin Impurity 46](/) |
Dapagliflozin Impurity 46 |
|
|
![Brexpiprazole Impurity ABCDEFGHJKL](/) |
Brexpiprazole Impurity ABCDEFGHJKL |
|
|
![4,4'-(2-ピリジニルメチレン)ビスフェノール](/CAS/GIF/603-41-8.gif) |
4,4'-(2-ピリジニルメチレン)ビスフェノール |
603-41-8 |
C18H15NO2 |
![Tazobactam Impurity DBT](/) |
Tazobactam Impurity DBT |
|
|
![3β-[4-O-[4-O-(2,6-ジデオキシ-β-D-ribo-ヘキソピラノシル)-2,6-ジデオキシ-β-D-ribo-ヘキソピラノシル]-2,6-ジデオキシ-β-D-ribo-ヘキソピラノシルオキシ]-12β,14,16β-トリヒドロキシ-5β-カルダ-20(22)-エノリド](/CAS/20180808/GIF/52589-12-5.gif) |
3β-[4-O-[4-O-(2,6-ジデオキシ-β-D-ribo-ヘキソピラノシル)-2,6-ジデオキシ-β-D-ribo-ヘキソピラノシル]-2,6-ジデオキシ-β-D-ribo-ヘキソピラノシルオキシ]-12β,14,16β-トリヒドロキシ-5β-カルダ-20(22)-エノリド |
52589-12-5 |
C41H64O15 |
![Thiophene, 2-(2-fluorophenyl)-5-[(5-iodo-2-methylphenyl)methyl]-](/CAS/20210305/GIF/2436275-33-9.gif) |
Thiophene, 2-(2-fluorophenyl)-5-[(5-iodo-2-methylphenyl)methyl]- |
2436275-33-9 |
C18H14FIS |
![Revefenacin Impurity 2](/CAS/20210305/GIF/1158699-78-5.gif) |
Revefenacin Impurity 2 |
1158699-78-5 |
C14H17NO4 |
![(R)-2-(4-Methoxyphenyl)-1-methylethanamine](/CAS/GIF/58993-79-6.gif) |
(R)-2-(4-Methoxyphenyl)-1-methylethanamine |
58993-79-6 |
C10H15NO |
![N-[5-[(1RS)-2-[benzyl[(1RS)-2-(4-methoxyphenyl)- 1-methylethyl]amino]-1-hydroxyethyl]-2- hydroxyphenyl]formamide](/CAS/20210305/GIF/2514947-17-0.gif) |
N-[5-[(1RS)-2-[benzyl[(1RS)-2-(4-methoxyphenyl)- 1-methylethyl]amino]-1-hydroxyethyl]-2- hydroxyphenyl]formamide |
2514947-17-0 |
C26H30N2O4 |
![Peramivir dehydrated deacetylated impurity](/) |
Peramivir dehydrated deacetylated impurity |
|
|
![Cilastatin Impurity H](/) |
Cilastatin Impurity H |
|
|
![(trans, trans)-3,3'-(1,4,7,10-tetraazacyclododecane-1,7-diyl)bis(butane-1,2,4-triol)](/) |
(trans, trans)-3,3'-(1,4,7,10-tetraazacyclododecane-1,7-diyl)bis(butane-1,2,4-triol) |
|
|
![Azelastine Impurity K](/) |
Azelastine Impurity K |
|
|
![Tofacitinib Impurity 90](/) |
Tofacitinib Impurity 90 |
|
|
![Nintedanib Impurity M](/) |
Nintedanib Impurity M |
|
|
![Citalopram Impurity 14](/CAS/20210111/GIF/1470362-85-6.gif) |
Citalopram Impurity 14 |
1470362-85-6 |
C20H23FN2O2 |
![(S)-methyl 2-(2,3-bis(hydroxymethyl)-6,7-dihydrothieno[3,2-c] pyridin-5(4H)-yl)-2-(2-chlorophenyl)acetate](/CAS/20200119/GIF/1346231-36-4.gif) |
(S)-methyl 2-(2,3-bis(hydroxymethyl)-6,7-dihydrothieno[3,2-c] pyridin-5(4H)-yl)-2-(2-chlorophenyl)acetate |
1346231-36-4 |
C18H20ClNO4S |
![Capecitabine impurity 6](/) |
Capecitabine impurity 6 |
|
|
![Vilanterol Impurity 25](/CAS/20210111/GIF/1027529-99-2.gif) |
Vilanterol Impurity 25 |
1027529-99-2 |
C13H15NO4 |
![Sugammadex sodium Org139131-1 Impurity](/) |
Sugammadex sodium Org139131-1 Impurity |
|
|
![Dolutegravir Impurity 16](/CAS/20200515/GIF/1357289-37-2.gif) |
Dolutegravir Impurity 16 |
1357289-37-2 |
C20H19F2N3O5 |
![Tofacitinib Impurity 98](/) |
Tofacitinib Impurity 98 |
|
|
![Cabozantinib impurity 30](/) |
Cabozantinib impurity 30 |
|
|
![Cabozantinib impurity 35](/) |
Cabozantinib impurity 35 |
1905820-17-8 |
|
![Carvedilol Impurity DBA](/CAS/20200611/GIF/3258-70-6.gif) |
Carvedilol Impurity DBA |
3258-70-6 |
C18H23NO4 |
![Pregabalin Impurity 9](/CAS/20200611/GIF/44855-96-1.gif) |
Pregabalin Impurity 9 |
44855-96-1 |
C5H7NO3 |
![Butyphthalide impurity 50](/) |
Butyphthalide impurity 50 |
|
|
![Canagliflozin Impurity 40](/) |
Canagliflozin Impurity 40 |
|
|
![Pralatrexate Impurity 4](/CAS/20210111/GIF/1445586-42-4.gif) |
Pralatrexate Impurity 4 |
1445586-42-4 |
C18H15N5O3 |
![Pralatrexate Impurity 9](/CAS/20200611/GIF/1548618-61-6.gif) |
Pralatrexate Impurity 9 |
1548618-61-6 |
C23H22N6O6 |
![N-(3-chloro-4-fluorophenyl)-7 -methoxy-6-(3-morpholinopropoxy)-N-(3-morpholinopropyl)quinazolin-4-amine](/CAS/20180702/GIF/1502829-45-9.gif) |
N-(3-chloro-4-fluorophenyl)-7 -methoxy-6-(3-morpholinopropoxy)-N-(3-morpholinopropyl)quinazolin-4-amine |
1502829-45-9 |
C29H37ClFN5O4 |
![(4R,6R)-6-(2-((1S,2S)-2,6-dimethyl-1,2,3,4-tetrahydronaphthalen-1-](/) |
(4R,6R)-6-(2-((1S,2S)-2,6-dimethyl-1,2,3,4-tetrahydronaphthalen-1- |
|
|
![Carbazochrome Sodium Sulfonate Impurity 1](/) |
Carbazochrome Sodium Sulfonate Impurity 1 |
|
|
![Rosuvastatin Impurity 147](/) |
Rosuvastatin Impurity 147 |
|
|
![Febuxostat Impurity 15 Complete Set](/) |
Febuxostat Impurity 15 Complete Set |
|
|
![Cetrorelix Impurity 10](/) |
Cetrorelix Impurity 10 |
|
|
![Cetrorelix Impurity 3 (9-D-Pro)](/) |
Cetrorelix Impurity 3 (9-D-Pro) |
|
|
![Peramivir Intermediate Impurity 42](/) |
Peramivir Intermediate Impurity 42 |
|
|
![Nintedanib impurity A drops](/) |
Nintedanib impurity A drops |
|
|
![Tofacitinib impurity N drops](/) |
Tofacitinib impurity N drops |
|
|
![Carboprost impurity 999](/) |
Carboprost impurity 999 |
|
|
![Bumetanide impurity C drops](/) |
Bumetanide impurity C drops |
|
|
![Troxipide Impurity 6](/) |
Troxipide Impurity 6 |
|
|
![Piperacillin Impurity K](/) |
Piperacillin Impurity K |
|
|
![2-(6'-oxo-1'-phenyl-1',6'-dihydro-[2,3'-bipyridin]-5'-yl)benzoic acid](/) |
2-(6'-oxo-1'-phenyl-1',6'-dihydro-[2,3'-bipyridin]-5'-yl)benzoic acid |
|
|
![3-Thiophenecarboxylic acid, 4-methyl-5-(4-nitrophenyl)-2-[(propoxycarbonyl)amino]-, ethyl ester](/CAS/20210305/GIF/2591260-03-4.gif) |
3-Thiophenecarboxylic acid, 4-methyl-5-(4-nitrophenyl)-2-[(propoxycarbonyl)amino]-, ethyl ester |
2591260-03-4 |
C18H20N2O6S |
![Pemetrexed disodium Impurity 32](/) |
Pemetrexed disodium Impurity 32 |
|
|
![Androsta-1,4-diene-17-carboxylic acid, 11,16,17-trihydroxy-3-oxo-, (11β,16α,17α)-](/CAS/20210305/GIF/1185143-75-2.gif) |
Androsta-1,4-diene-17-carboxylic acid, 11,16,17-trihydroxy-3-oxo-, (11β,16α,17α)- |
1185143-75-2 |
C20H26O6 |
![Tazobactam Impurity LTE](/) |
Tazobactam Impurity LTE |
|
|
![Isavuconazole Impurity 47](/) |
Isavuconazole Impurity 47 |
|
|
![5,5'-((1R,1'R)-((5,6-diethyl-2,3-dihydro-1H-inden-2-yl)azanediyl)bis(1-hydroxyethane-2,1-diyl))bis(8-(benzyloxy)quinolin-2(1H)-one)](/CAS/20211123/GIF/753498-27-0.gif) |
5,5'-((1R,1'R)-((5,6-diethyl-2,3-dihydro-1H-inden-2-yl)azanediyl)bis(1-hydroxyethane-2,1-diyl))bis(8-(benzyloxy)quinolin-2(1H)-one) |
753498-27-0 |
C49H49N3O6 |
![2-((6S,8S,9S,10R,11S,13S,14S,17S)-11-hydroxy-6,10,13-trimethyl-3-oxo- 6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl)-2-oxoacetic acid](/) |
2-((6S,8S,9S,10R,11S,13S,14S,17S)-11-hydroxy-6,10,13-trimethyl-3-oxo- 6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl)-2-oxoacetic acid |
|
|
![Pitavastatin Impurity 47](/) |
Pitavastatin Impurity 47 |
|
|
![Lenvatinib Impurity 38](/) |
Lenvatinib Impurity 38 |
|
|
![Tazobactam Impurity 9](/) |
Tazobactam Impurity 9 |
|
|
![Doxofylline Impurity 11](/CAS/20210111/GIF/109403-76-1.gif) |
Doxofylline Impurity 11 |
109403-76-1 |
C15H16N8O4 |
![5-(hydroxymethyl)-1,2-dihydro-1,2,4-triazol-3-one](/CAS/20180703/GIF/24021-90-7.gif) |
5-(hydroxymethyl)-1,2-dihydro-1,2,4-triazol-3-one |
24021-90-7 |
C3H5N3O2 |
![( 2-{4-[N-(5,6-diphenylpyrazin-2-yl)-N-isopropylamino]butyloxy}acetic acid tert-butylester )](/CAS/20180702/GIF/475084-96-9.gif) |
( 2-{4-[N-(5,6-diphenylpyrazin-2-yl)-N-isopropylamino]butyloxy}acetic acid tert-butylester ) |
475084-96-9 |
C29H37N3O3 |
![4-(1,4,8,11-テトラアザシクロテトラデカン-1-イルメチル)ベンゼンメタノール](/CAS/20180702/GIF/176252-20-3.gif) |
4-(1,4,8,11-テトラアザシクロテトラデカン-1-イルメチル)ベンゼンメタノール |
176252-20-3 |
C18H32N4O |
![Alvimopan Impurity 3](/) |
Alvimopan Impurity 3 |
|
|
![Nicergoline Impurity G](/) |
Nicergoline Impurity G |
|
|
![Isavuconazole Impurity 1](/CAS/20210111/GIF/2069200-13-9.gif) |
Isavuconazole Impurity 1 |
2069200-13-9 |
C13H12F2N4O |
![Sofosbuvir Impurity23](/) |
Sofosbuvir Impurity23 |
|
|
![Tacrolimus Impurity 1](/) |
Tacrolimus Impurity 1 |
|
|
![Bisoprolol EP Impurity F](/CAS/20180703/GIF/1798418-82-2.gif) |
Bisoprolol EP Impurity F |
1798418-82-2 |
C18H31NO4 |
![Pantoprazole EP Impurity F](/CAS/20200515/GIF/721924-06-7.gif) |
Pantoprazole EP Impurity F |
721924-06-7 |
C17H17F2N3O4S |
![Rosuvastatin EP Impurity E](/) |
Rosuvastatin EP Impurity E |
|
|
![Tiotropium EP Impurity C](/CAS/20211123/GIF/136310-95-7.gif) |
Tiotropium EP Impurity C |
136310-95-7 |
C19H22BrNO3S2 |
![Eliglustat intermediate 4](/CAS/20211123/GIF/491833-27-3.gif) |
Eliglustat intermediate 4 |
491833-27-3 |
C23H30N2O4 |
![2-[(4-アセチルフェニル)メチル]シクロペンタン-1-オン](/CAS/20180703/GIF/96824-28-1.gif) |
2-[(4-アセチルフェニル)メチル]シクロペンタン-1-オン |
96824-28-1 |
C14H16O2 |
![Dapoxetine Impurity 1](/CAS/20211123/GIF/119357-22-1.gif) |
Dapoxetine Impurity 1 |
119357-22-1 |
C22H25NO |
![Mirabegron Impurity 5](/) |
Mirabegron Impurity 5 |
|
|
![Milrinone Impurity 5](/) |
Milrinone Impurity 5 |
|
|
![Solifenacin Related Compound 20](/CAS/20200515/GIF/1300713-32-9.gif) |
Solifenacin Related Compound 20 |
1300713-32-9 |
C17H17NO |
![Cefuroxime Impurity 2](/CAS/20200119/GIF/CB43127931.gif) |
Cefuroxime Impurity 2 |
|
C16H16N4O8S |
![Cefoxitin Impurity 1](/) |
Cefoxitin Impurity 1 |
|
|
![Cefazolin Impurity 1](/) |
Cefazolin Impurity 1 |
|
|